Meto Zerok 25

Meto Zerok 25 is a medicine authorised by Swissmedic under authorisation number 56969. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 September 2005 and the authorisation is valid without a time limit. ATC code C07AB02 places the medicine in the group Beta blocking agents.

  • Dispensing category B
  • Authorisation number 56969
  • ATC C07AB02
  • Synthetic medicines
Authorisation data
Authorisation number56969
NameMeto Zerok 25
Full nameMeto Zerok 25, Retardtabletten
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC07AB02
First authorisation21 September 2005
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Meto Zerok 25, RetardtablettenB28 September 2007
2Meto Zerok 50, RetardtablettenB21 September 2005
3Meto Zerok 100, RetardtablettenB21 September 2005
4Meto Zerok 200, RetardtablettenB21 September 2005

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1430Tablette(n)C07AB0202.03.0.B
16100Tablette(n)C07AB0202.03.0.B
230Tablette(n)C07AB0202.03.0.B
4100Tablette(n)C07AB0202.03.0.B
630Tablette(n)C07AB0202.03.0.B
8100Tablette(n)C07AB0202.03.0.B
1030Tablette(n)C07AB0202.03.0.B
12100Tablette(n)C07AB0202.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Meto Zerok 25 authorised in Switzerland?

Yes. Meto Zerok 25 is authorised by Swissmedic under authorisation number 56969, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Meto Zerok 25 have?

Meto Zerok 25 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Meto Zerok 25?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com